The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
Open accessAbstract
Current medical practice artificially dichotomises a diagnosis of fatty liver disease into one of two common forms: alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD). Together, these account for the majority of chronic liver diseases worldwide. In recent years, there has been a dramatic increase in the prevalence of obesity and metabolic syndrome within the general population. These factors now coexist with alcohol consumption in a substantial proportion of the population. Each exposure sensitises the liver to the injurious effects of the other; an interaction that drives and potentially accelerates the genesis of liver disease. We review the epidemiological evidence and scientific literature that considers how alcohol consumption interacts with components of the metabolic syndrome to exert synergistic or supra-additive effects on the development and progression of liver disease, before discussing how these interactions may be addressed in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597 · cited 3×
“The 2014 WHO Report on Non-Communicable Diseases found that 39% of adults (38% of males and 40% of females) worldwide were overweight, with a near twofold increase in the prevalence of obesity between 1980 and 2014 [13].”
MethodInfluentialGlobal burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249
Self-citationEASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864 · cited 1×
“A reduced number of dopamine (D2) receptors have been observed in the brain of obese individuals and those with chronic alcohol abuse disorders[184, 185].”
BackgroundAlcohol consumption and mortality among middle-aged and elderly U.S. adults
Thun, M. J., Peto, R., Lopez, A. D., Monaco, J. H., Henley, S. J., Heath, C. W., & Doll, R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372401 · Cited by 1,313
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234 · cited 1×
“[52, 53] and ALD [48], but is protective against dyslipidaemia and cardiovascular disease [54-56].”
BackgroundA meta-analysis of alcohol consumption and the risk of 15 diseases
Corrao, G. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2003.11.027 · Cited by 1,077
Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis
McPherson, S., Hardy, T., Dufour, J.-F., Petta, S., Romero-Gomez, M., Allison, M., Oliveira, C. P., Francque, S., Van Gaal, L., Schattenberg, J. M., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.453 · Cited by 945
Self-citation
Research works printed but not linked: 175
- Chalasani, 2012, The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association, Hepatology, 55, 2005, 10.1002/hep.25762 · DOI · Paper page
- Anstee, 2016, Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease, Gastroenterology, 150, 1728, 10.1053/j.gastro.2016.01.037 · DOI · Paper page
- Anstee, 2013, Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis, Nat Rev Gastroenterol Hepatol, 10, 330, 10.1038/nrgastro.2013.41 · DOI · Paper page
- Younossi, 2011, Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008, Clin Gastroenterol Hepatol, 9, 524, 10.1016/j.cgh.2011.03.020 · DOI · Paper page
- Kraus, 2015, Changes in mortality due to major alcohol-related diseases in four Nordic countries, France and Germany between 1980 and 2009: a comparative age-period-cohort analysis, Addiction, 110, 1443, 10.1111/add.12989 · DOI
- Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 · DOI · Paper page
- Hayashi, 2004, Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related, Am J Gastroenterol, 99, 76, 10.1046/j.1572-0241.2003.04013.x · DOI
- Wannamethee, 2003, Alcohol, body weight, and weight gain in middle-aged men, Am J Clin Nutr, 77, 1312, 10.1093/ajcn/77.5.1312 · DOI · Paper page
- Rissanen, 1991, Determinants of weight gain and overweight in adult Finns, Eur J Clin Nutr, 45, 419
- Bendsen, 2013, Is beer consumption related to measures of abdominal and general obesity? A systematic review and meta-analysis, Nutr Rev, 71, 67, 10.1111/j.1753-4887.2012.00548.x · DOI
- Fazzino, 2017, Heavy drinking in young adulthood increases risk of transitioning to obesity, Am J Prev Med, 53, 169, 10.1016/j.amepre.2017.02.007 · DOI
- Baumeister, 2005, Health Risk drinking and problematic consumption of alcohol in Pomerania: comparative analysis of the Study of Health in Pomerania (SHIP) compared with the Federal German Health and Examination Survey in 1998, Gesundheitswesen, 67, 39, 10.1055/s-2004-813829 · DOI
- Kotronen, 2010, Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey, BMC Public Health, 10, 237, 10.1186/1471-2458-10-237 · DOI
- Forgione, 2007, Alcoholic and nonalcoholic forms of fatty liver disease, Minerva Gastroenterol Dietol, 53, 83
- Nagata, 2007, Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis, J Toxicol Sci, 32, 453, 10.2131/jts.32.453 · DOI · Paper page
- Arteel, 2003, Oxidants and antioxidants in alcohol-induced liver disease, Gastroenterology, 124, 778, 10.1053/gast.2003.50087 · DOI · Paper page
- Clark, 2002, Nonalcoholic fatty liver disease, Gastroenterology, 122, 1649, 10.1053/gast.2002.33573 · DOI · Paper page
- Sakaguchi, 2011, Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress, Drug Metab Pharmacokinet, 26, 30, 10.2133/dmpk.DMPK-10-RV-087 · DOI
- Diehl, 2001, Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis, Alcohol Clin Exp Res, 25, 8S, 10.1111/j.1530-0277.2001.tb02368.x · DOI
- Sabate, 2008, High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis, Obes Surg, 18, 371, 10.1007/s11695-007-9398-2 · DOI · Paper page
- Cope, 2000, Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis, Gastroenterology, 119, 1340, 10.1053/gast.2000.19267 · DOI · Paper page
- Baker, 2010, Role of alcohol metabolism in non-alcoholic steatohepatitis, PLoS One, 5, e9570, 10.1371/journal.pone.0009570 · DOI · Paper page
- de Medeiros, 2015, Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis, Med Hypotheses, 85, 148, 10.1016/j.mehy.2015.04.021 · DOI
- Mezey, 1975, Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity, Am J Clin Nutr, 28, 1277, 10.1093/ajcn/28.11.1277 · DOI
- Baraona, 1986, Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats, Gastroenterology, 90, 103, 10.1016/0016-5085(86)90081-8 · DOI · Paper page
- Picot, 1997, Hellegouarc'h R, Gastroenterol Clin Biol, 21, 562
- Karahanian, 2011, Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects, Alcohol Clin Exp Res, 35, 606, 10.1111/j.1530-0277.2011.01439.x · DOI
- Ye, 2013, Cytochrome P4502E1 inhibitor, chlormethiazole, decreases lipopolysaccharide-induced inflammation in rat Kupffer cells with ethanol treatment, Hepatol Res, 43, 1115, 10.1111/hepr.12063 · DOI
- Lindros, 1983, Uninterrupted prolonged ethanol oxidation as a main pathogenetic factor of alcoholic liver damage: evidence from a new liquid diet animal model, Liver, 3, 79, 10.1111/j.1600-0676.1983.tb00854.x · DOI
- Kovach, 2001, Inhibition of alcohol dehydrogenase blocks enhanced Gi-protein expression following ethanol treatment in experimental hepatocellular carcinoma in vitro, Eur J Gastroenterol Hepatol, 13, 1209, 10.1097/00042737-200110000-00014 · DOI
- Wilson, 2006, Characterization of the human patatin-like phospholipase family, J Lipid Res, 47, 1940, 10.1194/jlr.M600185-JLR200 · DOI · Paper page
- Valenti, 2010, Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease, Hepatology, 51, 1209, 10.1002/hep.23622 · DOI · Paper page
- Tian, 2010, Variant in PNPLA3 is associated with alcoholic liver disease, Nat Genet, 42, 21, 10.1038/ng.488 · DOI · Paper page
- Stickel, 2011, Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians, Hepatology, 53, 86, 10.1002/hep.24017 · DOI · Paper page
- Trepo, 2011, Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease, J Hepatol, 55, 906, 10.1016/j.jhep.2011.01.028 · DOI
- Kahali, 2015, TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?, Gastroenterology, 148, 679, 10.1053/j.gastro.2015.01.038 · DOI
- Anstee, 2015, The genetics of nonalcoholic fatty liver disease: spotlight on PNPLA3 and TM6SF2, Semin Liver Dis, 35, 270, 10.1055/s-0035-1562947 · DOI · Paper page
- Heba, 2016, Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference, J Magn Reson Imaging, 43, 398, 10.1002/jmri.25006 · DOI
- Liangpunsakul, 2012, What should we recommend to our patients with NAFLD regarding alcohol use?, Am J Gastroenterol, 107, 976, 10.1038/ajg.2012.20 · DOI
- Lazo, 2014, Alcohol consumption and hepatic steatosis in the general US population, J Hepatol, 60, S13, 10.1016/S0168-8278(14)60032-5 · doi:10.1016/s0168-8278(14)60032-5
- O'Shea, 2010, Practice Guideline Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G, Alcoholic liver disease, Hepatology, 51, 307, 10.1002/hep.23258 · DOI · Paper page
- Farrell, 2007, Asia-Pacific Working Party on N. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary, J Gastroenterol Hepatol, 22, 775, 10.1111/j.1440-1746.2007.05002.x · DOI · Paper page
- Chokshi, 2015, J-shaped curves and public health, JAMA, 314, 1339, 10.1001/jama.2015.9566 · DOI
- Sato, 2012, Relationship between drinking patterns and the risk of type 2 diabetes: the Kansai Healthcare Study, J Epidemiol Community Health, 66, 507, 10.1136/jech.2010.109777 · DOI
- Hong, 2015, High-risk drinking is associated with a higher risk of diabetes mellitus in Korean men, based on the 2010–2012 KNHANES, Alcohol, 49, 275, 10.1016/j.alcohol.2015.02.004 · DOI
- Cullmann, 2012, Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population, Diabetic Med, 29, 441, 10.1111/j.1464-5491.2011.03450.x · DOI · Paper page
- Wechsler, 1998, Binge drinking: the five/four measure, J Stud Alcohol, 59, 122, 10.15288/jsa.1998.59.122 · DOI · Paper page
- Barrio, 2004, Liver disease in heavy drinkers with and without alcohol withdrawal syndrome, Alcohol Clin Exp Res, 28, 131, 10.1097/01.ALC.0000106301.39746.EB · DOI
- Nanji, 1985, Relationship between pork consumption and cirrhosis, Lancet, 1, 681, 10.1016/S0140-6736(85)91338-8 · DOI
- Nanji, 1989, Beef fat prevents alcoholic liver disease in the rat, Alcohol Clin Exp Res, 13, 15, 10.1111/j.1530-0277.1989.tb00276.x · DOI · Paper page
- Buettner, 2006, Defining high-fat-diet rat models: metabolic and molecular effects of different fat types, J Mol Endocrinol, 36, 485, 10.1677/jme.1.01909 · DOI · Paper page
- Tipoe, 2009, Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD), Histol Histopathol, 24, 1161
- Bergheim, 2008, Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin, J Hepatol, 48, 983, 10.1016/j.jhep.2008.01.035 · DOI · Paper page
- Feldstein, 2003, Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice, J Hepatol, 39, 978, 10.1016/S0168-8278(03)00460-4 · DOI · Paper page
- Johansen, 2006, Food buying habits of people who buy wine or beer: cross sectional study, BMJ, 332, 519, 10.1136/bmj.38694.568981.80 · DOI
- Barefoot, 2002, Alcoholic beverage preference, diet, and health habits in the UNC Alumni Heart Study, Am J Clin Nutr, 76, 466, 10.1093/ajcn/76.2.466 · DOI · Paper page
- Ruidavets, 2004, Alcohol intake and diet in France, the prominent role of lifestyle, Eur Heart J, 25, 1153, 10.1016/j.ehj.2003.12.022 · DOI
- Tjonneland, 1999, Wine intake and diet in a random sample of 48763 Danish men and women, Am J Clin Nutr, 69, 49, 10.1093/ajcn/69.1.49 · DOI · Paper page
- Kasdallah-Grissa, 2006, Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats, Alcohol Alcohol, 41, 236, 10.1093/alcalc/agh256 · DOI
- Ajmo, 2008, Resveratrol alleviates alcoholic fatty liver in mice, Am J Physiol Gastrointest Liver Physiol, 295, G833, 10.1152/ajpgi.90358.2008 · DOI · Paper page
- Kanuri, 2015, Effect of acute beer ingestion on the liver: studies in female mice, Eur J Nutr, 54, 465, 10.1007/s00394-014-0730-z · DOI
- Obara, 2009, Isohumulones, the bitter component of beer, improve hyperglycemia and decrease body fat in Japanese subjects with prediabetes, Clin Nutr, 28, 278, 10.1016/j.clnu.2009.03.012 · doi:10.1016/j.clnu.2009.03.012
- Pelletier, 2002, Wine consumption is not associated with a decreased risk of alcoholic cirrhosis in heavy drinkers, Alcohol Alcoholism, 37, 618, 10.1093/alcalc/37.6.618 · DOI
- Holst, 2017, Alcohol drinking patterns and risk of diabetes: a cohort study of 70,551 men and women from the general Danish population, Diabetologia, 60, 1941, 10.1007/s00125-017-4359-3 · DOI
- Purohit, 2008, Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium, Alcohol, 42, 349, 10.1016/j.alcohol.2008.03.131 · DOI · Paper page
- Lieber, 1965, Effects of prolonged ethanol intake: production of fatty liver despite adequate diets, J Clin Invest, 44, 1009, 10.1172/JCI105200 · DOI · Paper page
- Lieber, 1986, The feeding of ethanol in liquid diets, Alcohol Clin Exp Res, 10, 550, 10.1111/j.1530-0277.1986.tb05140.x · DOI · Paper page
- Duly, 2015, Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity, Nutr Diabetes, 5, e154, 10.1038/nutd.2015.4 · DOI
- Kanuri, 2016, Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice, Eur J Nutr, 55, 1153, 10.1007/s00394-015-0929-7 · DOI
- Hu, 1996, AdipoQ is a novel adipose-specific gene dysregulated in obesity, J Biol Chem, 271, 10697, 10.1074/jbc.271.18.10697 · DOI · Paper page
- McPherson, 2015, Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management, J Hepatol, 62, 1148, 10.1016/j.jhep.2014.11.034 · DOI · Paper page
- Bellentani, 2000, Prevalence of and risk factors for hepatic steatosis in Northern Italy, Ann Intern Med, 132, 112, 10.7326/0003-4819-132-2-200001180-00004 · DOI · Paper page
- Ruhl, 2005, Joint effects of body weight and alcohol on elevated serum alanine aminotransferase in the United States population, Clin Gastroenterol Hepatol, 3, 1260, 10.1016/S1542-3565(05)00743-3 · DOI · Paper page
- Alatalo, 2008, Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index, Am J Clin Nutr, 88, 1097, 10.1093/ajcn/88.4.1097 · DOI
- Loomba, 2009, Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study, Aliment Pharmacol Ther, 30, 1137, 10.1111/j.1365-2036.2009.04141.x · DOI
- Raynard, 2002, Risk factors of fibrosis in alcohol-induced liver disease, Hepatology, 35, 635, 10.1053/jhep.2002.31782 · DOI · Paper page
- Ekstedt, 2009, Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease, Scand J Gastroenterol, 44, 366, 10.1080/00365520802555991 · DOI · Paper page
- Aberg, 2017, Binge drinking and the risk of liver events: A population-based cohort study, Liver Int, 37, 1373, 10.1111/liv.13408 · DOI
- Seitz, 2015, Effect of chronic alcohol consumption on the development and progression of non-alcoholic fatty liver disease (NAFLD), Hepatobiliary Surg Nutr, 4, 147
- Klatsky, 2014, Moderate alcohol intake and cancer: the role of underreporting, Cancer Causes Control, 25, 693, 10.1007/s10552-014-0372-8 · DOI
- Hashimoto, 2015, Modest alcohol consumption reduces the incidence of fatty liver in men: a population-based large-scale cohort study, J Gastroenterol Hepatol, 30, 546, 10.1111/jgh.12786 · DOI
- Petersen, 1977, Fatty liver in patients with moderate alcohol consumption, diabetes mellitus and overweight, Scand J Gastroenterol, 12, 781, 10.3109/00365527709181720 · DOI
- Cotrim, 2009, Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients, Eur J Gastroenterol Hepatol, 21, 969, 10.1097/MEG.0b013e328328f3ec · DOI
- Dixon, 2001, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese, Gastroenterology, 121, 91, 10.1053/gast.2001.25540 · DOI · Paper page
- Kwon, 2014, Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease, Liver Int, 34, 129, 10.1111/liv.12230 · DOI
- Dunn, 2012, Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD), J Hepatol, 57, 384, 10.1016/j.jhep.2012.03.024 · DOI · Paper page
- Hagstrom, 2017, Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease, Scand J Gastroenterol, 52, 159, 10.1080/00365521.2016.1239759 · DOI
- Mukamal, 2006, Alcohol consumption and self-reported sunburn: a cross-sectional, population-based survey, J Am Acad Dermatol, 55, 584, 10.1016/j.jaad.2006.04.033 · DOI
- Fillmore, 1998, Alcohol consumption and mortality. I. Characteristics of drinking groups, Addiction, 93, 183, 10.1046/j.1360-0443.1998.9321834.x · DOI
- La Vecchia, 1995, Prevalence of chronic diseases in alcohol abstainers, Epidemiology, 6, 436, 10.1097/00001648-199507000-00021 · DOI
- Suh, 2015, Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index, Cancer, 121, 3818, 10.1002/cncr.29577 · DOI
- Lazo, 2013, Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988–1994, Am J Epidemiol, 178, 38, 10.1093/aje/kws448 · DOI · Paper page
- Argo, 2009, Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis, J Hepatol, 51, 371, 10.1016/j.jhep.2009.03.019 · DOI · Paper page
- Longato, 2012, Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease, Oxid Med Cell Longev, 2012, 479348, 10.1155/2012/479348 · DOI
- Stepanova, 2010, Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study, Gut, 59, 1410, 10.1136/gut.2010.213553 · DOI · Paper page
- Bhagat, 2009, Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis vs. patients with cirrhosis due to alcoholic liver disease, Liver Transpl, 15, 1814, 10.1002/lt.21927 · DOI · Paper page
- Yan, 2012, Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease, World J Hepatol, 4, 110, 10.4254/wjh.v4.i4.110 · DOI
- Finelli, 2013, What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?, World J Gastroenterol, 19, 802, 10.3748/wjg.v19.i6.802 · DOI · Paper page
- Rogers, 2008, Adiponectin and alcoholic fatty liver disease, IUBMB Life, 60, 790, 10.1002/iub.124 · DOI
- Yi, 2016, Impact of alcohol consumption and body mass index on mortality from nonneoplastic liver diseases, upper aerodigestive tract cancers, and alcohol use disorders in Korean older middle-aged men: Prospective cohort study, Medicine, 95, e4876, 10.1097/MD.0000000000004876 · DOI
- Kawamura, 2016, Effects of alcohol consumption on hepatocarcinogenesis in japanese patients with fatty liver disease, Clin Gastroenterol Hepatol, 14, 597, 10.1016/j.cgh.2015.11.019 · DOI
- Loomba, 2010, Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men, Clin Gastroenterol Hepatol, 8, 891, 10.1016/j.cgh.2010.06.027 · DOI
- Singal, 2014, The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis, Am J Gastroenterol, 109, 325, 10.1038/ajg.2013.476 · DOI · Paper page
- Salameh, 2015, PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease, Am J Gastroenterol, 110, 846, 10.1038/ajg.2015.137 · DOI
- Liu, 2014, Carriage of the PNPLA3 rs738409 C>G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma, J Hepatol, 61, 75, 10.1016/j.jhep.2014.02.030 · DOI · Paper page
- Marrero, 2005, Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma, J Hepatol, 42, 218, 10.1016/j.jhep.2004.10.005 · DOI · Paper page
- Adams, 2017, Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases, Gut, 66, 1138, 10.1136/gutjnl-2017-313884 · DOI · Paper page
- Pietraszek, 2010, Alcohol and type 2 diabetes. A review, Nutr Metab Cardiovasc Dis, 20, 366, 10.1016/j.numecd.2010.05.001 · DOI · Paper page
- Sinn, 2014, Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease, Atherosclerosis, 234, 270, 10.1016/j.atherosclerosis.2014.03.001 · DOI
- Klatsky, 2009, Alcohol and cardiovascular diseases, Expert Rev Cardiovasc Ther, 7, 499, 10.1586/erc.09.22 · DOI
- Marks, 2012, Calorie and alcohol consumption in nonalcoholic fatty liver disease, Eur J Gastroenterol Hepatol, 24, 527, 10.1097/MEG.0b013e3283514edb · DOI
- Bell, 1994, Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department, Alcohol Clin Exp Res, 18, 1103, 10.1111/j.1530-0277.1994.tb00088.x · DOI
- Seitz, 2006, Additive effects of moderate drinking and obesity on serum gamma-glutamyl transferase, Am J Clin Nutr, 83, 1252, 10.1093/ajcn/83.6.1252 · DOI
- Imbert-Bismut, 2001, Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study, Lancet, 357, 1069, 10.1016/S0140-6736(00)04258-6 · DOI · Paper page
- Nalpas, 1986, Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit, Hepatology, 6, 608, 10.1002/hep.1840060410 · DOI
- Williams, 1988, Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis, Gastroenterology, 95, 734, 10.1016/S0016-5085(88)80022-2 · DOI · Paper page
- Nyblom, 2004, High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking, Alcohol Alcohol, 39, 336, 10.1093/alcalc/agh074 · DOI · Paper page
- McPherson, 2010, Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease, Gut, 59, 1265, 10.1136/gut.2010.216077 · DOI · Paper page
- Angulo, 2007, The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD, Hepatology, 45, 846, 10.1002/hep.21496 · DOI · Paper page
- Vallet-Pichard, 2007, FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest, Hepatology, 46, 32, 10.1002/hep.21669 · DOI · Paper page
- Mitchell, 2014, Absorption and peak blood alcohol concentration after drinking beer, wine, or spirits, Alcohol Clin Exp Res, 38, 1200, 10.1111/acer.12355 · DOI
- Chrostek, 2012, The diagnostic power of direct carbohydrate-deficient transferrin immunoassay in alcoholics. Absolute or relative values?, Alcohol, 46, 69, 10.1016/j.alcohol.2011.08.010 · DOI
- Fagan, 2013, BMI but not stage or etiology of nonalcoholic liver disease affects the diagnostic utility of carbohydrate-deficient transferrin, Alcohol Clin Exp Res, 37, 1771, 10.1111/acer.12143 · DOI
- Stewart. Alcohol. Clin Exp Res 2013;1:150–155. · DOI
- Staufer, 2011, Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption, Hepatology, 54, 1640, 10.1002/hep.24596 · DOI
- Coulton, 2006, Opportunistic screening for alcohol use disorders in primary care: comparative study, BMJ, 332, 511, 10.1136/bmj.38743.421574.7C · DOI
- Hagedorn, 2007, Does gastric bypass alter alcohol metabolism?, Surg Obes Related Dis, 3, 543, 10.1016/j.soard.2007.07.003 · DOI · Paper page
- Maluenda, 2010, Alcohol absorption modification after a laparoscopic sleeve gastrectomy due to obesity, Obes Surg, 20, 744, 10.1007/s11695-010-0136-9 · DOI
- Yoder, 2017, How do individuals develop alcohol use disorder after bariatric surgery? A grounded theory exploration, Obes Surg
- Mitchell, 2001, Long-term follow-up of patients' status after gastric bypass, Obes Surg, 11, 464, 10.1381/096089201321209341 · DOI · Paper page
- Ertelt, 2008, Alcohol abuse and dependence before and after bariatric surgery: a review of the literature and report of a new data set, Surg Obes Related Dis, 4, 647, 10.1016/j.soard.2008.01.004 · DOI · Paper page
- King, 2012, Prevalence of alcohol use disorders before and after bariatric surgery, JAMA, 307, 2516, 10.1001/jama.2012.6147 · DOI · Paper page
- King, 2017, Alcohol and other substance use after bariatric surgery: prospective evidence from a U.S. multicenter cohort study, Surg Obesity Related Dis, 13, 1392, 10.1016/j.soard.2017.03.021 · DOI · Paper page
- Ostlund, 2013, Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery, JAMA Surg, 148, 374, 10.1001/jamasurg.2013.700 · DOI
- Conason, 2013, Substance use following bariatric weight loss surgery, JAMA Surg, 148, 145, 10.1001/2013.jamasurg.265 · DOI · Paper page
- Wee, 2014, High-risk alcohol use after weight loss surgery, Surg Obes Related Dis, 10, 508, 10.1016/j.soard.2013.12.014 · DOI
- Barry, 2009, Associations between body mass index and substance use disorders differ by gender: results from the National Epidemiologic Survey on Alcohol and Related Conditions, Addict Behav, 34, 51, 10.1016/j.addbeh.2008.08.008 · DOI
- Barry, 2008, Gender differences in associations between body mass index and DSM-IV mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions, Ann Epidemiol, 18, 458, 10.1016/j.annepidem.2007.12.009 · DOI · Paper page
- Scott, 2008, Obesity and mental disorders in the general population: results from the world mental health surveys, Int J Obes, 32, 192, 10.1038/sj.ijo.0803701 · DOI · Paper page
- Abizaid, 2006, Thoughts for food: brain mechanisms and peripheral energy balance, Neuron, 51, 691, 10.1016/j.neuron.2006.08.025 · DOI
- Volkow, 2000, Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex, Cereb Cortex, 10, 318, 10.1093/cercor/10.3.318 · DOI · Paper page
- Kiefer, 2001, Leptin: a modulator of alcohol craving?, Biol Psychiatry, 49, 782, 10.1016/S0006-3223(01)01081-2 · DOI
- 2009, CDC. Cigarette smoking among adults and trends in smoking cessation -United States 2008, MMWR Morb Mortal Wkly Rep, 58, 1227
- Yeh, 2010, Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study, Ann Intern Med, 152, 10, 10.7326/0003-4819-152-1-201001050-00005 · DOI · Paper page
- Janzon, 2004, Changes in blood pressure and body weight following smoking cessation in women, J Intern Med, 255, 266, 10.1046/j.1365-2796.2003.01293.x · DOI
- Karsenty, 1985, Paradoxical effect of ethanol on liver lipogenesis in the genetically-obese Zucker rat, Br J Nutr, 54, 15, 10.1079/BJN19850087 · doi:10.1079/bjn19850087
- Carmiel-Haggai, 2003, Binge ethanol exposure increases liver injury in obese rats, Gastroenterology, 125, 1818, 10.1053/j.gastro.2003.09.019 · DOI
- Olleros, 2008, Fat diet and alcohol-induced steatohepatitis after LPS challenge in mice: role of bioactive TNF and Th1 type cytokines, Cytokine, 44, 118, 10.1016/j.cyto.2008.07.001 · DOI
- Wang, 2009, Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease, Hepatology, 50, 453, 10.1002/hep.22978 · DOI
- Wang, 2010, Moderate alcohol consumption aggravates high-fat diet induced steatohepatitis in rats, Alcohol Clin Exp Res, 34, 567, 10.1111/j.1530-0277.2009.01122.x · DOI
- Gabele, 2011, A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis, Alcohol Clin Exp Res, 35, 1361, 10.1111/j.1530-0277.2011.01472.x · DOI
- Xu, 2011, Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK, J Hepatol, 55, 673, 10.1016/j.jhep.2010.12.034 · DOI · Paper page
- Everitt, 2013, Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice, Am J Physiol Gastrointest Liver Physiol, 304, G38, 10.1152/ajpgi.00309.2012 · DOI
- Nascimento, 2013, Aggravation of nonalcoholic steatohepatitis by moderate alcohol consumption is associated with decreased SIRT1 activity in rats, Hepatobiliary Surg Nutr, 2, 252
- Duryee, 2014, Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis, Am J Physiol Gastrointest Liver Physiol, 306, G208, 10.1152/ajpgi.00124.2013 · DOI
- Minato, 2014, Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis, Mol Med, 20, 490, 10.2119/molmed.2014.00048 · DOI
- Alwahsh, 2014, Combination of alcohol and fructose exacerbates metabolic imbalance in terms of hepatic damage, dyslipidemia, and insulin resistance in rats, PLoS One, 9, e104220, 10.1371/journal.pone.0104220 · DOI
- Chang, 2015, Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1, Hepatology, 62, 1070, 10.1002/hep.27921 · DOI · Paper page
- Song, 2016, Chronic alcohol consumption causes liver injury in high-fructose-fed male mice through enhanced hepatic inflammatory response, Alcohol Clin Exp Res, 40, 518, 10.1111/acer.12994 · DOI
- Lau, 2015, The combined effects of alcohol consumption and body mass index on hepatic steatosis in a general population sample of European men and women, Aliment Pharmacol Ther, 41, 467, 10.1111/apt.13067 · DOI
- Suzuki, 2007, Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia, Am J Gastroenterol, 102, 1912, 10.1111/j.1572-0241.2007.01274.x · DOI
- Dunn, 2008, Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease, Hepatology, 47, 1947, 10.1002/hep.22292 · DOI · Paper page
- Gunji, 2009, Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population, Am J Gastroenterol, 104, 2189, 10.1038/ajg.2009.361 · DOI
- Yamada, 2010, Alcohol drinking may not be a major risk factor for fatty liver in Japanese undergoing a health checkup, Dig Dis Sci, 55, 176, 10.1007/s10620-008-0693-0 · DOI
- Shen, 2010, A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels, Eur J Gastroenterol Hepatol, 22, 820, 10.1097/MEG.0b013e3283328b86 · DOI
- Hiramine, 2011, Alcohol drinking patterns and the risk of fatty liver in Japanese men, J Gastroenterol, 46, 519, 10.1007/s00535-010-0336-z · DOI
- Moriya, 2011, Alcohol consumption appears to protect against non-alcoholic fatty liver disease, Aliment Pharmacol Ther, 33, 378, 10.1111/j.1365-2036.2010.04520.x · DOI
- Hamaguchi, 2012, Protective effect of alcohol consumption for fatty liver but not metabolic syndrome, World J Gastroenterol, 18, 156, 10.3748/wjg.v18.i2.156 · DOI
- Wong, 2012, Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography, Gut, 61, 409, 10.1136/gutjnl-2011-300342 · DOI · Paper page
- Taniai, 2012, Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease, Hepatol Res, 42, 359, 10.1111/j.1872-034X.2011.00935.x · DOI
- Moriya, 2015, Roles of alcohol consumption in fatty liver: a longitudinal study, J Hepatol, 62, 921, 10.1016/j.jhep.2014.11.025 · DOI
- Takahashi, 2015, Biphasic effect of alcohol intake on the development of fatty liver disease, J Gastroenterol, 50, 1114, 10.1007/s00535-015-1058-z · DOI
- Dunn, 2012, The interaction of rs738409, obesity, and alcohol: a population-based autopsy study, Am J Gastroenterol, 107, 1668, 10.1038/ajg.2012.285 · DOI
- Ascha, 2010, The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, Hepatology, 51, 1972, 10.1002/hep.23527 · DOI · Paper page
- Pais, 2015, Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants, Clin Gastroenterol Hepatol, 13, 992, 10.1016/j.cgh.2014.10.011 · DOI
Cited by
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Self-citationMAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease
Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286
Self-citationFrom NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Self-citationSeitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Comparison of MAFLD and NAFLD diagnostic criteria in real world
Lin, S., Huang, J., Wang, M., Kumar, R., Liu, Y., Liu, S., Wu, Y., Wang, X., & Zhu, Y. (2020) · Liver International · doi:10.1111/liv.14548 · Cited by 516
Metadata
- Authors
- Boyle, M., Masson, S., & Anstee, Q. M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 68
- Issue
- 2
- Pages
- 251-267
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2766791134
- Cited by
- 159
- References
- 43
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. https://app.cochat.ai/papers/10.1016/j.jhep.2017.11.006
- The paper
- Boyle, M., Masson, S., & Anstee, Q. M. (2018). The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2017.11.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.